← Alliance of Automobile Manufacturers
FDANonrulemakingFDA-2015-N-0045

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AH-7921; Gamma-Butyrolactone (GBL); 1,4-Butanediol; 9 Additional Substances; Request for Comments

RIN
—
Last modified
Dec 30, 2015
Comment window
closed 3939d ago
Alliance of Automobile Manufacturers filings
1

Activity

Alliance of Automobile Manufacturers filed 1 comment on this docket between Feb 27, 2015 and Feb 27, 2015. 62 other organizations filed here. The comment window closed 3939d ago.

What Alliance of Automobile Manufacturers filed (1)

Feb 27, 2015· Comment from Alliance of Automobile Manufacturers et al· FDA-2015-N-0045-0029

These comments are submitted on behalf of the members of the Alliance of Automobile Manufacturers, the Association of Global Automakers, Inc., the Motor & Equipment Manufacturers Association and the Truck and Engine Manufacturers Association, regarding this FDA notice and request for comment. Collectively, our associations include nearly every manufacturer of new passenger vehicles as well as commercial vehicles and their suppliers that manufacture vehicle parts, components and systems. Specifically, our comment letter addresses the potential impact of the World Health Organizations recommendations to list 1,4-butanediol (BDO) and gamma-butyrolactone (GBL) under Schedule I of the 1971 United Nations Convention on Psychotropic Substances (1971 Convention) on our industry. The attached file is our complete comment letter.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (62)

See everyone who commented →